Skip to main content
Clinical Trials/ACTRN12617000661370
ACTRN12617000661370
Completed
Not Applicable

Comparison of the effects of Spinal Anesthesia on QT Dispersion in women electing to undergo Caesarean section: prospective study.

Harran University School of Medicine, Research and Training Hospital0 sites40 target enrollmentMay 8, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
otherwise healthy parturients planned for cesarean section
Sponsor
Harran University School of Medicine, Research and Training Hospital
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 8, 2017
End Date
January 8, 2018
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Harran University School of Medicine, Research and Training Hospital

Eligibility Criteria

Inclusion Criteria

  • Forty pregnant women age between greater than or equal to 18 and less than or equal to 45,
  • height greater than or equal to 1\.60 cm, weight between greater than or equal to 60 and less than or equal to 100 kg,
  • placed in the ASA risk group I\-II in their preanesthetic evaluation and scheduled for elective cesarean surgery will included in the study.

Exclusion Criteria

  • Exclusion criteria is refusal to participate in the study, the existence of brain tumors, scalded skin syndrome (SSS infection), spinal cord and peripheral nervous system diseases (poliomyelitis, multiple sclerosis, demyelinating diseases), hemorrhagic and hypovolemic shock, severe anemia, increased intracranial pressure, aortic and valvular heart disease, cardiac decompensation, systemic infection (generalized sepsis and bacteremia), local infection (dermal infections in puncture site of spinal needle, etc.), congenital spinal anomalies, scoliosis, post\-traumatic vertebral injuries, vertebral colon metastatic lesions, increased abdominal pressure, chronic severe headache, anticoagulant drug use and anatomic diffi culties, electrolyte disturbances diabetes mellitus, hypothyroidism, hyperthyroidism, cardiomyopathy, atrial and/or ventricular hypertrophy on ECG, cardiomegaly, valvular disease, cardiac failure or chronic disease, patients with excessive smoking and alcohol consumption and used medication causing QT interval prolongation.

Outcomes

Primary Outcomes

Not specified

Similar Trials